Table 4.
Alteplase group |
Control group |
Adjusted analysis* |
Unadjusted analysis† |
|||||
---|---|---|---|---|---|---|---|---|
n | Mean (SE) | n | Mean (SE) | Mean difference (SE) | p value | Mean difference (SE) | p value | |
Visual analogue scale score | 653 | 62·07 (0·90) | 648 | 60·57 (0·91) | 2·18 (1·21) | 0·072 | 1·49 (1·28) | 0·244 |
EQ utility index | 674 | 0·550 (0·015) | 667 | 0·502 (0·016) | 0·062 (0·020) | 0·002 | 0·049 (0·022) | 0·028 |
Adjusted for age, National Institutes of Health Stroke Scale score, delay from onset to enrolment, and presence of visible ischaemia on the baseline scan.
Significance based on t test. Utility based on UK time trade-off valuations on a scale of −1 to +1.